This review of obesity treatments in adults concluded that there are beneficial effects of orlistat, sibutramine and metformin and low-fat diets, and that exercise and/or behaviour therapy appear to improve weight loss when added to diet. The review was generally well-conducted and the conclusions are likely to be reliable.
Assessment of study quality
Methodological quality was assessed by rating the following features of each study: allocation concealment, handling of withdrawals and drop-outs, and the blinding of participants, health care providers and outcome assessors. One reviewer completed the quality assessment and a second reviewer checked it; neither was blinded to the author, institution or journal. Any disagreements were resolved by discussion, or by referral to a third reviewer if required.
Data extraction
One reviewer extracted the data into a standard form. A second reviewer checked the extraction and any disagreements were resolved by discussion, or by referral to a third reviewer if required. Where only graphical data were available, these were analysed using a computer. Intention-to-treat analyses were used where available. A weighted mean difference (WMD) and 95% confidence interval (CI) were calculated for continuous data, while an odds ratio and 95% CI were calculated for dichotomous data. Where there were multiple comparisons with the same control group, the control group was split for dichotomous data but used more than once for continuous data. Further details of the data transformation and how missing data were imputed were provided.
Methods of synthesis
How were the studies combined? The studies were grouped by intervention and comparator and were combined by meta-analysis with a fixed-effect model, weighting by the inverse of the variance. Where it was not possible to combine the studies quantitatively, a narrative synthesis was undertaken.
How were differences between studies investigated?
Statistical heterogeneity was assessed using the chi-squared test and I2 statistic. Where there was evidence of heterogeneity, possible causes were discussed in the text of the review.
Results of the review
Eighty-four RCTs were included in the review.
Drug interventions: the long-term weight change with orlistat and sibutramine in conjunction with diet was significantly greater than with placebo and diet. The WMD was -3.01 kg (95% CI: -3.48, -2.54) with orlistat at 24 months and 4.12 kg (95% CI: -4.97, -3.26 with sibutramine at 18 months. Blood lipid levels also decreased with both drugs, but only orlistat was associated with a fall in blood-pressure. Metformin and SSRIs were not associated with significant weight loss over 12 months. However the UK Prospective Diabetes Study found metformin to be associated with decreased mortality at 10 years in diabetic participants. There was insufficient evidence on the effects of acarbose.
Dietary interventions: a low-fat or 600 kcal/day diet was associated with a significant weight change, compared with control, at 12 months (WMD -5.31 kg, 95% CI: -5.86, -4.77) and also at 24 and 36 months. It was also associated with the prevention of type 2 diabetes and improved control of hypertension. The protein-sparing modified fast was not shown to have a greater effect on weight than a low-fat or 600 kcal/day diet. There was insufficient evidence to assess the putative benefits of low-calorie or very low-calorie diets.
Exercise and behaviour therapy: the addition of an exercise programme to diet was associated with additional weight change at 12 months (WMD -1.95 kg, 95% CI: -3.22, -0.68), along with improvements in blood lipids. The addition of behaviour therapy to diet was also associated with additional weight change (WMD -7.67 kg, 95% CI: -11.97, -3.36). It was unclear whether the addition of both exercise and behaviour therapy further enhanced weight loss.
Mode of delivery: family therapy was associated with more weight change than individual treatment at 12 months (WMD -2.96 kg, 95% CI: -5.31, -0.60). There was insufficient evidence to assess group versus individual therapy.
